Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 50.70
+1.95 (4.00%)
Apr 17, 2026, 1:59 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 10.22 billion as of April 17, 2026. Its market cap has increased by 139.40% in one year.
Market Cap
10.22B
Enterprise Value
9.77B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.70
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 10.22B, an increase of 3.47%. That is a compound annual growth rate of 0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 10.22B | 77.74% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.56B |
| Ever Supreme Bio Technology | 12.26B |
| CHO Pharma | 11.56B |
| Tanvex BioPharma | 10.86B |
| PharmaEngine | 8.46B |
| Gongwin Biopharm Holdings | 8.18B |